hsa-mir-106a RT-PCR检测试剂盒 英文名称: hsa-mir-106a RT-PCR Detection Kit 品牌: Abbexa 货号: abx096089 规格: 50 rxns 价格: $362.5 产品说明书下载: 产品预定 >> 产品预定,提交订单信息之后,我们会第一时间与您取得联系 试剂和工具 试剂...
Hsa-miR-106a在胃癌组织中的表达及其临床意义
Objective To investigate the effects of hsa_circ_0045943 targeting miR-106a on the biological characteristics of gastric cancer cells and its mechanism. Methods Human gastric cancer cells MKN-45,AGS and gastric mucosal epithelial cells GES-1 were cultured;circ_0045943 was detected...
The down-regulation of hsa-miR-137 in astrocytomas was shown to be associated with advanced clinical stages of this disease. Using Kaplan–Meier survival analysis we showed that low expression of hsa-miR-181b or hsa-miR-106a, or high expression of hsa-miR-21 was significantly associated ...
专利名称 微小核苷酸hsa-miR939在高血压诊断中的应用 申请号 201410543613X 申请日期 2013-11-26 公布/公告号 CN104357554B 公布/公告日期 2016-08-24 发明人 张腾,陈瑜,贾成林,杨琴波,王培伟,李黎,崔金刚,杜宵烨,宁冰冰,刘丽 专利申请人 上海中医药大学附属岳阳中西医结合医院 专利代理人 李阳 专利代理机构 上...
Identification of specific miRNA dysregulation patterns in MS blood samples compared to healthy control can be used as a diagnostic and prognostic agent. Through the literature review and bioinformatics analysis, it was found that the hsa-miR-106a-5p can be considered a significant MS pathogenic ...
DATA SHEET Hsa-miR-106a ProbeFremontTel
Sharma A, Kumar M, Aich J, Hariharan M, Brahmachari SK, Agrawal A, et al. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. PNAS 2009;106:5761-6.Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. A Sharma,M Kumar,J Aich,M Hariharan,...
Finally, molecular studies were conducted to compare hsa-miR-106a-5p and hsa-miR-181a-5p expression in the control and treated groups.#According to the study, Peiminine has been found to enhance the cytotoxicity of Doxorubicin, which reduces cell viability and increases apoptosis in the AGS ...
TREATMENT OF AN IN VITRO CULTURED CELL LINE WITH AN ANTISENSE DNA OLIGOMER OF hsa-miR-106b miRNA AND A METHOD FOR CHANGING A SIGNAL TRANSDUCTION SYSTEMPURPOSE: A treatment of an in vitro cultured cell line with an antisense DNA oligomer of hsa-miR-106b miRNA and a method for changing a ...